The Goldman Sachs Group, Inc. (GS) 13D/13G Filings for Taysha Gene Therapies, Inc. (TSHA)

The Goldman Sachs Group, Inc. 13D and 13G filings for Taysha Gene Therapies, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-07-03
12:23 pm
Purchase		 2025-06-26 13G Taysha Gene Therapies, Inc.
TSHA		 GOLDMAN SACHS GROUP INC
GS		 12,748,968
5.100%		 12,748,968increase
(New Position)		 Filing